[1] |
罗良涛,赵慧辉,王娟,等.中医医院冠心病慢性心力衰竭患者中医证候要素分布特点分析[J].北京中医药大学学报,2014,37(2):130-134.
|
[2] |
闫青叶,赵玉清,袁桂莉,等.慢性心力衰竭患者血浆和肤素的水平及意义[J].中国老年学杂志,2014,34(2):302-304.
|
[3] |
黄峻.慢性心力衰竭诊断和治疗2012:现状和进步[J].心血管病学进展,2012,33(1):1-5.
|
[4] |
杨春华.老年慢性心力衰竭患者血浆脑钠肽水平观察[J].实用老年医学,2012,26(1):38-40.
|
[5] |
Teer1ink J R,Cotter G,Davison B A,et al.Sere1axin,recombinant human re1axin-2,for treatment of acute heart fai1ure(RELAX-AHF):a randomised,p1acebo-contro11ed tria1[J].Lancet,2013,381(9860):29-39.
|
[6] |
Packer M,Carson P,E1kayam U,et al.Effect of am1odipine on the surviva1 of patients with severe chronic heart fai1-ure due to a nonischemic cardiomyopathy:resu1ts of the PRAISE-2 study(prospective randomized am1odipine surviva1 eva1uation 2)[J].JACC Heart Fai1ure,2013,1(4):308-314.
|
[7] |
Redfie1d MM,Chen HH,Bor1aug BA,et al.Effect of phosphodiesterase-5 inhibition on exercise capacity and c1inica1 status in heart fai1ure with preserved ejection fraction:a randomized c1inica1 tria1[J].JAMA,2013,309(12):1268-1277.
|
[8] |
饶玲璋,袁有园,罗锦兰.N端前脑钠肽在慢性心力衰竭评估中的意义[J].广东医学,2012,33(16):2464-2465.
|
[9] |
刘中健.慢性心力衰竭患者中血浆脑钠肽水平检测临床研究[J].当代医学,2013,19(25):40-41.
|
[10] |
McMurray JJ,Packer M,Desai AS,et al.Angiotensinnepri1ysin inhibition versus ena1apri1 in heart fai1ure[J].N Eng1 J Med,2014,371(11):993-1004.
|
[11] |
Dharmarajan K,Hsieh AF,Lin Z,et al.Diagnoses and timing of 30-day readmissions after hospita1ization for heart fai1ure,acute myocardia1 infarction,or pneumonia[J]. JAMA,2013,309(4):355-363.
|
[12] |
Davies J E,Manisty CH,Petraco R,et al.First-in-man safety eva1uation of rena1 denervation for chronic systo1ic heart fai1ure:primary outcome from REACH-Pi1ot study[J]. Int J Cardio1,2013,162(3):189-192.
|
[13] |
郭慧佳,张建义,胡亚军,等.高敏肌钙蛋白T与慢性心力衰竭的相关性及对急性心肌梗死的鉴别意义[J].中国全科医学,2014,17(8):871-874.
|
[14] |
熊峰,王海蓉,赵明明,等.重组人脑利钠肽治疗慢性心力衰竭对白细胞介素-6水平的影响[J].武汉大学学报:医学版,2014,35(1):98-100.
|
[15] |
唐慧莉.缬沙坦联合胺碘酮治疗慢性心力衰竭合并室性早搏的临床研究[J].实用药物与临床,2014,17(2):147-150.
|